Cubist Pharmaceuticals reports first quarter 2014 financial results
Cubist reported 2014 first quarter total net revenues were $261.2 million, up 14% compared to $229.9 million in the same 2013 quarter. GAAP operating income was $28.3 million compared to $9.8 million in the first quarter of 2013. April 22, 2014